Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09AA03	ZESTRIL	B	Lisinopril (dihydrate) - 20mg	20mg	Tablet	636,981 L.L
C10AA01	ZOCOR	B	Simvastatin - 20mg	20mg	Tablet	976,526 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 200mg/8ml	200mg/8ml	Injectable concentrate for solution	63,807,499 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 200mg/8ml	200mg/8ml	Injectable concentrate for solution	63,807,499 L.L
J01FA10	ZOMAX	G	Azithromycin (dihydrate) - 200mg/5ml	200mg/5ml	Powder for suspension	258,018 L.L
J05AB01	ZOVIRAX	B	Aciclovir - 200mg/5ml	200mg/5ml	Suspension	487,815 L.L
N02CC03	ZOLMITRIPTAN ARROW GENERIGUES	G	Zolmitriptan - 2.5mg	2.5mg	Tablet, film coated	1,726,838 L.L
N02CC03	ZOLMITRIPTAN ARROW GENERIGUES	G	Zolmitriptan - 2.5mg	2.5mg	Tablet, film coated	857,372 L.L
N02CC03	ZOLMITRIPTAN BIOGARAN	G	Zolmitriptan - 2.5mg	2.5mg	Tablet, orodispersible	921,876 L.L
N02CC03	ZOLMITRIPTAN BIOGARAN	G	Zolmitriptan - 2.5mg	2.5mg	Tablet, orodispersible	1,683,835 L.L
L02BG03	ZORTEX	G	Anastrozole - 1mg	1mg	Tablet, film coated	1,944,092 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 1g	1g	Injectable lyophilised powder for solution	1,066,115 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 1g	1g	Injectable lyophilised powder for solution	6,911,190 L.L
C08DB01	ZALDEM CR	G	Diltiazem HCl - 180mg	180mg	Capsule, controlled release	966,287 L.L
B01AF01	ZARLAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	2,015,764 L.L
B01AF01	ZARLAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,343,843 L.L
N05AX12	ZALONIL	G	Aripiprazole - 15mg	15mg	Tablet, orodispersible	2,426,980 L.L
C09CA04	ZIOREL	G	Irbesartan - 150mg	150mg	Tablet, film coated	575,933 L.L
C08DB01	ZALDEM CR	G	Diltiazem HCl - 120mg	120mg	Capsule, controlled release	517,059 L.L
B01AF01	ZARLAN	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	1,439,255 L.L
A10BK01	ZYGLOR 10	G	Dapagliflozin - 10mg	10mg	Tablet, film coated	2,039,953 L.L
R06AE07	ZYRTEC	B	Cetirizine (dihydrochloride) - 10mg	10mg	Tablet, film coated	593,978 L.L
N06AB10	ZELAX 10	G	Escitalopram (oxalate) - 10mg	10mg	Caplet	833,182 L.L
C10AX09	ZEMIL	G	Ezetimibe - 10mg	10mg	Tablet	944,529 L.L
N05AH03	ZYPREXA VELOTAB	B	Olanzapine - 10mg	10mg	Tablet, dispersible	5,214,109 L.L
N05AH03	ZYPREXA VELOTAB	B	Olanzapine - 10mg	10mg	Tablet, dispersible	5,214,109 L.L
N05AH03	ZOLAPINE	G	Olanzapine - 10mg	10mg	Tablet, orodispersible	2,106,249 L.L
N05AH03	ZYRWAN OD	G	Olanzapine - 10mg	10mg	Tablet, orodispersible	2,564,819 L.L
N05AH03	ZYPREXA	B	Olanzapine - 10mg	10mg	Tablet	1,468,820 L.L
N05AH03	ZYPREXA	B	Olanzapine - 10mg	10mg	Tablet	1,468,820 L.L